These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38381878)

  • 21. Serum cytokine profile in leprosy and its correlation with clinico-histopathological profile.
    Madan NK; Agarwal K; Chander R
    Lepr Rev; 2011 Dec; 82(4):371-82. PubMed ID: 22439277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy.
    Trao VT; Huong PL; Thuan AT; Anh DD; Trach DD; Rook GA; Wright EP
    Immunology; 1998 Jun; 94(2):197-206. PubMed ID: 9741341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytokines as biomarkers to monitoring the impact of multidrug therapy in immune response of leprosy patients.
    Cassirer-Costa F; Medeiros NI; Chaves AT; Lyon S; Coelho-Dos-Reis JGA; Ribeiro-Junior AF; Correa-Oliveira R; Rocha MOC; Gomes JAS
    Cytokine; 2017 Sep; 97():42-48. PubMed ID: 28570932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.
    Geluk A; van der Ploeg-van Schip JJ; van Meijgaarden KE; Commandeur S; Drijfhout JW; Benckhuijsen WE; Franken KL; Naafs B; Ottenhoff TH
    Clin Vaccine Immunol; 2010 Jun; 17(6):993-1004. PubMed ID: 20427628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered cytokine profiles in relapsed paucibacillary leprosy: a case report.
    Sameshima T; Maeda Y; Mukai T; Goto M
    BMC Infect Dis; 2021 Nov; 21(1):1155. PubMed ID: 34774006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease.
    van Hooij A; van den Eeden SJF; Khatun M; Soren S; Franken KLMC; Chandra Roy J; Alam K; Chowdhury AS; Richardus JH; Geluk A
    Vaccine; 2021 Dec; 39(50):7230-7237. PubMed ID: 34688497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Th1/Th2 and macrophage lineage cytokines in leprosy; correlation with circulating CD4(+) CD25(high) FoxP3(+) T-regs cells.
    Abdallah M; Attia EA; Saad AA; El-Khateeb EA; Lotfi RA; Abdallah M; El-Shennawy D
    Exp Dermatol; 2014 Oct; 23(10):742-7. PubMed ID: 25109693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S; Finiasz DM; Fink S; Valdez R; Bottasso O; Balina LM; Sasiain MC
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):45-55. PubMed ID: 9207753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect.
    Aleman M; De La Barrera S; Fink S; Finiasz M; Farina MH; Pizzariello G; Sasiain MD
    Scand J Immunol; 2000 Mar; 51(3):262-70. PubMed ID: 10736095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.
    Mizoguti Dde F; Hungria EM; Freitas AA; Oliveira RM; Cardoso LP; Costa MB; Sousa AL; Duthie MS; Stefani MM
    Mem Inst Oswaldo Cruz; 2015 Nov; 110(7):914-20. PubMed ID: 26560982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy Impairment Is Associated With Increased Inflammasome Activation and Reversal Reaction Development in Multibacillary Leprosy.
    de Mattos Barbosa MG; de Andrade Silva BJ; Assis TQ; da Silva Prata RB; Ferreira H; Andrade PR; da Paixão de Oliveira JA; Sperandio da Silva GM; da Costa Nery JA; Sarno EN; Pinheiro RO
    Front Immunol; 2018; 9():1223. PubMed ID: 29915584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of antigen-specific immune responses for leprosy diagnosis in a hyperendemic area in China.
    Chen X; You YG; Yuan YH; Yuan LC; Zhang Y; Yan W
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006777. PubMed ID: 30248098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae.
    Misra N; Murtaza A; Walker B; Narayan NP; Misra RS; Ramesh V; Singh S; Colston MJ; Nath I
    Immunology; 1995 Sep; 86(1):97-103. PubMed ID: 7590888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum CCL2 concomitant with a reduced mycobacterium-induced response leads to disease dissemination in leprosy.
    Hasan Z; Jamil B; Zaidi I; Zafar S; Khan AA; Hussain R
    Scand J Immunol; 2006 Mar; 63(3):241-7. PubMed ID: 16499578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced vitamin D receptor (VDR) and cathelicidin antimicrobial peptide (CAMP) gene expression contribute to the maintenance of inflammatory immune response in leprosy patients.
    Grossi de Oliveira AL; Chaves AT; Cardoso MS; Pinheiro GRG; Antunes DE; Grossi MAF; Lyon S; Bueno LL; Rocha MODC; Menezes CADS; Fujiwara RT
    Microbes Infect; 2022 Sep; 24(6-7):104981. PubMed ID: 35462022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between Central Memory T Cell Expression and Proinflammatory Cytokine Production with Clinical Presentation of Multibacillary Leprosy Relapse.
    Esquenazi D; Alvim IM; Pinheiro RO; Oliveira EB; Moreira Lde O; Sarno EN; Nery JA
    PLoS One; 2015; 10(5):e0127416. PubMed ID: 25992795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soil-transmitted helminth infections and leprosy: a cross-sectional study of the association between two major neglected tropical diseases in Indonesia.
    Oktaria S; Effendi EH; Indriatmi W; van Hees CL; Thio HB; Sjamsoe-Daili ES
    BMC Infect Dis; 2016 Jun; 16():258. PubMed ID: 27278453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the immunological biomarker profile during acute Zika virus infection reveals the overexpression of CXCL10, a chemokine linked to neuronal damage.
    Naveca FG; Pontes GS; Chang AY; Silva GAVD; Nascimento VAD; Monteiro DCDS; Silva MSD; Abdalla LF; Santos JHA; Almeida TAP; Mejía MDCC; Mesquita TGR; Encarnação HVS; Gomes MS; Amaral LR; Campi-Azevedo AC; Coelho-Dos-Reis JG; Antonelli LRDV; Teixeira-Carvalho A; Martins-Filho OA; Ramasawmy R
    Mem Inst Oswaldo Cruz; 2018 May; 113(6):e170542. PubMed ID: 29768624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.